Cited by 753Liver Disease Diagnosis and TreatmentMitochondrial Function and PathologyDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 346 of the 348 references it cites were found in a registry or an index.

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

Begriche, Karima, Igoudjil, Anissa, Pessayre, Dominique, Fromenty, Bernard·2006·Mitochondrion

DOI 10.1016/j.mito.2005.10.004

Open this paper in CoChat — free account

Abstract

Calorie-enriched diet and lack of exercise are causing a worldwide surge of obesity, insulin resistance and lipid accretion in liver (i.e. hepatic steatosis), which can lead to steatohepatitis. Steatosis and nonalcoholic steatohepatitis (NASH) can also be induced by drugs such as amiodarone, tamoxifen and some antiretroviral drugs, including stavudine and zidovudine. There is accumulating evidence that mitochondrial dysfunction (more particularly respiratory chain deficiency) plays a key role in the physiopathology of NASH whatever its initial cause. In contrast, the mitochondrial beta-oxidation of fatty acids can be either increased (as in insulin resistance-associated NASH) or decreased (as in drug-induced NASH). However, in both circumstances, generation of reactive oxygen species (ROS) by the damaged respiratory chain can be augmented. ROS generation in an environment enriched in lipids in turn induces lipid peroxidation which releases highly reactive aldehydic derivatives (e.g. malondialdehyde) that have diverse detrimental effects on hepatocytes and other hepatic cells. In hepatocytes, ROS, reactive nitrogen species and lipid peroxidation products further impair the respiratory chain, either directly or indirectly through oxidative damage to the mitochondrial genome. This consequently leads to the generation of more ROS and a vicious cycle occurs. Mitochondrial dysfunction can also lead to apoptosis or necrosis depending on the energy status of the cell. ROS and lipid peroxidation products also increase the generation of several cytokines (TNF-alpha, TGF-beta, Fas ligand) playing a key role in cell death, inflammation and fibrosis. Recent investigations have shown that some genetic polymorphisms can significantly increase the risk of steatohepatitis and that several drugs can prevent or even reverse NASH. Interestingly, most of these drugs could exert their beneficial effects by improving directly or indirectly mitochondrial function in liver. Finding a drug, which could fully prevent oxidative stress and mitochondrial dysfunction in NASH is a major challenge for the next decade.

Integrity signals

Registry

Crossref · 10.1016/j.mito.2005.10.004

Cites

346 of 346 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 480
Retracted
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
The metabolic syndrome
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
The metabolic syndrome
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Obesity as a medical problem
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844

Flagged first, then by citations

Show all 348 references

2 of the 348 references couldn’t be matched to a known paper.

Research works printed but not linked: 6

Abbey-Toby, 2005, β-Aminoisobutyric acid alleviates steatohepatitis in a murine model of diabetes and obesity, Virchows Arch., 447, 305
Begriche, 2005, A thymine catabolite, β-aminoisobutyric acid, reduces hepatic dysfunction and metabolic disorders in overweight or obese mice, J. Hepatol., 42, 243
Fiorini, 2002, Primary non-function in steatotic livers is due to differential Toll-like expression and endotoxin sensitivity, Hepatology, 36, 198
Haque, 2002, Nonalcoholic steatohepatitis (NASH) is associated with hepatocyte mitochondrial DNA depletion, Hepatology, 36, 403
Igoudjil, 2005, Mitochondrial and metabolic disturbances induced by high dose of stavudine in mice are alleviated by coadministration of l-carnitine. Possible role of PPAR-α, J. Hepatol., 42, 247
Sutton, 2003, The Ala-9Val dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria, Pharmacogentics, 13, 145, 10.1097/00008571-200303000-00004 · DOI

Sorted by citations

Items 201–300 of 752

Protection against Hepatocyte Mitochondrial Dysfunction Delays Fibrosis Progression in Mice
Mitchell, C., Robin, M., Mayeuf-Louchart, A., Mahrouf‐Yorgov, M., Mansouri, A., Hamard, M., Couton, D., Fromenty, B., & Gilgenkrantz, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090332 · Cited by 70
A Silybin-Phospholipid Complex Prevents Mitochondrial Dysfunction in a Rodent Model of Nonalcoholic Steatohepatitis
Serviddio, G., Bellanti, F., Giudetti, A. M., Gnoni, G. V., Petrella, A., Tamborra, R., Romano, A. D., Rollo, T., Vendemiale, G., & Altomare, E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161612 · Cited by 67
ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy
Lu, W., Mei, J., Yang, J., Wu, Z., Liu, J., Miao, P., Chen, Y., Wen, Z., Zhao, Z., Kong, H., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117601 · Cited by 65
Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
Mazzolini, G. D., Sowa, J., Atorrasagasti, C., Kücükoglu, Ö., Syn, W., & Canbay, A. E. (2020) · Cells · doi:10.3390/cells9112458 · Cited by 65
Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease
Başaranoğlu, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2223 · Cited by 65
Anthocyanin‐rich extracts from blackberry, wild blueberry, strawberry, and chokeberry: antioxidant activity and inhibitory effect on oleic acid‐induced hepatic steatosis in vitro
Wang, Y., Zhao, L., Wang, D., Huo, Y., & Ji, B. (2015) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7370 · Cited by 64
Methionine Deficiency and Hepatic Injury in a Dietary Steatohepatitis Model
Oz, H. S., Chen, T. S., & Neuman, M. G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9900-7 · Cited by 65
Prevention of free fatty acid‐induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction
Jun, D. W., Cho, W. K., Jun, J. H., Kwon, H. J., Jang, K., Kim, H., Jeon, H. J., Lee, K. N., Lee, H. L., Lee, O. Y., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02602.x · Cited by 64
PTEN at the crossroad of metabolic diseases and cancer in the liver
Vinciguerra, M., & Foti, M. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31848-4 · Cited by 63
Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver
Moon, K., Upreti, V. V., Yu, L., Lee, I. J., Ye, X., Eddington, N. D., Veenstra, T. D., & Song, B. (2008) · PROTEOMICS · doi:10.1002/pmic.200800215 · Cited by 62
Pentose phosphate pathway activity parallels lipogenesis but not antioxidant processes in rat liver
Jin, E. S., Lee, M. H., Murphy, R. E., & Malloy, C. R. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00342.2017 · Cited by 62
Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner
Krishnan, K. C., Floyd, R. R., Sabir, S., Jayasekera, D. W., León‐Mimila, P., Jones, A. E., Cortez, A. A., Shravah, V., Péterfy, M., Stiles, L., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.09.004 · Cited by 62
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Gutiérrez‐Cuevas, J., Lucano‐Landeros, S., López-Cifuentes, D., Santos, A., & Armendáriz‐Borunda, J. (2022) · Cancers · doi:10.3390/cancers15010023 · Cited by 64
Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: A review of mechanisms and outcomes
McWhirter, D., Kitteringham, N. R., Jones, R. P., Malik, H., Park, K., & Palmer, D. H. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.05.011 · Cited by 62
Steatosis and steatohepatitis in postmortem material from Northwestern Greece
Zois, C. D. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i31.3944 · Cited by 62
Alterations in the redox state and liver damage: Hints from the EASL Basic School of Hepatology
Tell, G., Vascotto, C., & Tiribelli, C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.018 · Cited by 61
In vivo measurement of ethanol metabolism in the rat liver using magnetic resonance spectroscopy of hyperpolarized [1‐13C]pyruvate
Spielman, D. M., Mayer, D., Yen, Y., Tropp, J. S., Hurd, R. E., & Pfefferbaum, A. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21998 · Cited by 61
Functional Roles of Protein Nitration in Acute and Chronic Liver Diseases
Abdelmegeed, M. A., & Song, B. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/149627 · Cited by 62
Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion – Preliminary report
Laron, Z., Ginsberg, S., & Webb, M. (2008) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.03.003 · Cited by 61
Beneficial effects of Yerba Mate tea (Ilex paraguariensis) on hyperlipidemia in high-fat-fed hamsters
Gao, H., Long, Y., Jiang, X., Liu, Z., Wang, D., Zhao, Y., Li, D., & Sun, B. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.03.008 · Cited by 60
Antioxidant Therapy in Nonalcoholic Steatohepatitis
Al‐Busafi, S. A., Bhat, M., Wong, P. Y. N., Ghali, P., & Deschênes, M. (2012) · Hepatitis Research and Treatment · doi:10.1155/2012/947575 · Cited by 61
Dietary protein insufficiency: an important consideration in fatty liver disease?
Ampong, I., Watkins, A. J., Gutierrez‐Merino, J., Ikwuobe, J., & Griffiths, H. R. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519003064 · Cited by 63
Sex-specific genetic regulation of adipose mitochondria and metabolic syndrome by Ndufv2
Krishnan, K. C., Vergnes, L., Acín‐Pérez, R., Stiles, L., Shum, M., Ma, L., Mouisel, É., Pan, C., Moore, T. M., Péterfy, M., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00481-w · Cited by 61
Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes
Valdecantos, M. P., Prieto-Hontoria, P. L., Pardo, V., Mòdol, T., Santamaría, B., Weber, M., Herrero, L., Serra, D., Muntané, J., Cuadrado, A., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.019 · Cited by 58
Model Steatogenic Compounds (Amiodarone, Valproic Acid, and Tetracycline) Alter Lipid Metabolism by Different Mechanisms in Mouse Liver Slices
Szalowska, E., van der Burg, B., Man, H.-Y., Hendriksen, P. J. M., & Peijnenburg, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086795 · Cited by 59
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
Perumpail, B. J., Li, A. A., John, N., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G. T., Kim, D., & Ahmed, A. (2019) · Diseases · doi:10.3390/diseases7010027 · Cited by 60
An Intimate Relationship between ROS and Insulin Signalling: Implications for Antioxidant Treatment of Fatty Liver Disease
Besse‐Patin, A., & Estall, J. L. (2014) · International Journal of Cell Biology · doi:10.1155/2014/519153 · Cited by 63
Cytochrome P450-2E1 promotes aging-related hepatic steatosis, apoptosis and fibrosis through increased nitroxidative stress
Abdelmegeed, M. A., Choi, Y., Ha, S.-K., & Song, B. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.016 · Cited by 57
Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis
Schröder, T., Kucharczyk, D., Bär, F., Pagel, R., Derer, S., Jendrek, S. T., Sünderhauf, A., Brethack, A.-K., Hirose, M., Möller, S., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.010 · Cited by 57
Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man
Dragović, S., Vermeulen, N. P. E., Gerets, H. H. J., Hewitt, P. G., Ingelman‐Sundberg, M., Park, B. K., Juhila, S., Snoeys, J., & Weaver, R. J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1845-1 · Cited by 57
Drug-induced Liver Steatosis and Phospholipidosis: Cell-Based Assays for Early Screening of Drug Candidates
Donato, M. T., & Gómez-Lechón, M. J. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850001 · Cited by 59
Physical exercise prevents and mitigates non-alcoholic steatohepatitis-induced liver mitochondrial structural and bioenergetics impairments
Gonçalves, I. O., Passos, E., Rocha‐Rodrigues, S., Diogo, C. V., Torrella, J. R., Rizo‐Roca, D., Viscor, G., Alves, E. S., Marques‐Aleixo, I., Oliveira, P. J., et al. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.03.012 · Cited by 59
Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment
Zhang, R., Yan, Z., Zhong, H., Rong, L., Liu, W., Xiong, S., Liu, Q., & Liu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000484 · Cited by 57
Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in guinea pigs
Tveden‐Nyborg, P., Birck, M. M., Ipsen, D. H., Thiessen, T., Feldmann, L. D. B., Lindblad, M. M., Jensen, H. E., & Lykkesfeldt, J. (2015) · Translational research · doi:10.1016/j.trsl.2015.10.001 · Cited by 58
Antiplasmodial Activity of [(Aryl)arylsulfanylmethyl]Pyridine
Kumar, S., Das, S., Dey, S., Maity, P., Guha, M., Choubey, V., Panda, G., & Bandyopadhyay, U. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00898-07 · Cited by 52
Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
Dallio, M., Diano, N., Masarone, M., Gravina, A. G., Patanè, V., Romeo, M., Sarno, R. D., Errico, S., Nicolucci, C., Abenavoli, L., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173134 · Cited by 56
Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation
Luis, P. B., Ruiter, J. P. N., Aires, C. C. P., Soveral, G., de Almeida, I. T., Durán, M., Wanders, R. J. A., & Silva, M. F. B. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.06.007 · Cited by 56
Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo
Wang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 55
Nitric Oxide Plays a Crucial Role in the Development/Progression of Nonalcoholic Steatohepatitis in the Choline‐Deficient, l‐Amino Acid‐Defined Diet‐Fed Rat Model
Fujita, K., Nozaki, Y., Yoneda, M., Wada, K., Takahashi, H., Kirikoshi, H., Inamori, M., Saito, S., Iwasaki, T., Terauchi, Y., et al. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00756.x · Cited by 55
Beneficial Effects of Fermented Green Tea Extract in a Rat Model of Non-alcoholic Steatohepatitis
Nakamoto, K., Takayama, F., Mankura, M., Hidaka, Y., Egashira, T., Ogino, T., Kawasaki, H., & Mori, A. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-256 · Cited by 55
Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis
Sorrentino, P., Terracciano, L., D’Angelo, S., Ferbo, U., Bracigliano, A., Tarantino, L., Perrella, A., Perrella, O., Chiara, G. D., Panico, L., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0249-x · Cited by 57
Genetic determinants of mitochondrial content
Curran, J. E., Johnson, M. P., Dyer, T. D., Göring, H. H. H., Kent, J. W., Charlesworth, J., Borg, A. J., Jowett, J. B. M., Cole, S. A., MacCluer, J. W., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm101 · Cited by 54
Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series
Ferreira‐Hermosillo, A., Torres-Durán, P. V., & Juárez-Oropeza, M. A. (2010) · Journal of Medical Case Reports · doi:10.1186/1752-1947-4-103 · Cited by 54
Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis
Yang, R., Pan, Q., Liu, X., Zhou, D., Xin, F., Zhao, Z., Zhang, R.-N., Zeng, J., Qiao, L., Hu, C., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1118-0 · Cited by 54
The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
Méndez‐Sánchez, N., Valencia-Rodríguez, A., Coronel-Castillo, C. E., Vera-Barajas, A., Contreras-Carmona, J., Ponciano‐Rodríguez, G., & Zamora‐Valdés, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.184 · Cited by 55
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD
Ezhilarasan, D. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155912 · Cited by 54
The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis
Banasch, M., Ellrichmann, M., Tannapfel, A., Schmidt, W., & Goetze, O. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-6-258 · Cited by 53
Roles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis
Li, C. P., Li, J. H., He, S. Y., Li, P., & Zhong, X. L. (2014) · Genetics and Molecular Research · doi:10.4238/2014.may.23.10 · Cited by 53
Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure
Rennison, J. H., McElfresh, T. A., Chen, X., Anand, V. R., Hoit, B. D., Hoppel, C. L., & Chandler, M. P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.019 · Cited by 56
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
Ægidius, H. M., Veidal, S. S., Feigh, M., Hallenborg, P., Puglia, M., Pers, T. H., Vrang, N., Jelsing, J., Kornum, B. R., Blagoev, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58059-7 · Cited by 51
Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
Fierbinteanu-Braticevici, C. G., Băicuş, C., Tribus, L. C., & Papacocea, R. I. (2011) · PubMed · Cited by 52
Eicosapentaenoic Acid Attenuates Progression of Hepatic Fibrosis with Inhibition of Reactive Oxygen Species Production in Rats Fed Methionine- and Choline-Deficient Diet
Kajikawa, S., Imada, K., Takeuchi, T., Shimizu, Y., Kawashima, A., Harada, T., & Mizuguchi, K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1400-5 · Cited by 51
Mitochondrial Dysfunction and Ca2+ Overload in Injured Sertoli Cells Exposed to Bisphenol A
Wang, C., Qi, S., Liu, C., Aixia, Y., Fu, W., Quan, C., Duan, P., Yu, T., & Yang, K. (2016) · Environmental Toxicology · doi:10.1002/tox.22282 · Cited by 51
Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction
Xu, L., Nagata, N., & Ota, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235920 · Cited by 51
One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver
Sugasawa, T., Ono, S., Yonamine, M., Fujita, S.-I., Matsumoto, Y., Aoki, K., Nakano, T., Tamai, S., Yoshida, Y., Kawakami, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115851 · Cited by 51
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
Harini, K. S., & Ezhilarasan, D. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.10.003 · Cited by 53
Metabolic syndrome in pediatric cancer survivors: A mechanistic review
Rosen, G. P., Nguyen, H.-T., & Shaibi, G. Q. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24703 · Cited by 51
Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders
Lim, S. K., & Barter, P. J. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24398 · Cited by 53
Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis
Rafiei, H., Omidian, K., & Bandy, B. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600781 · Cited by 51
Enhanced ROS production leads to excessive fat accumulation through DAF-16 in Caenorhabditis elegans
Wang, K., Chen, S., Zhang, C., Huang, J., Wu, J., Zhou, H., Jin, L., Xu, Q., Jin, J., & Lyu, J. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.017 · Cited by 50
Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Lee, C., Kim, J., Wang, S., Sung, S., Kim, N., Lee, H., Seo, Y., & Jung, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092369 · Cited by 51
Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice
Begriche, K., Lettéron, P., Abbey‐Toby, A., Vadrot, N., Robin, M., Bado, A., Pessayre, D., & Fromenty, B. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00379.2007 · Cited by 49
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Lin, X., Zhang, J., Chu, Y., Nie, Q., & Zhang, J. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108593 · Cited by 56
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
Dua, A., KUMARI, R. R., Singh, M., Kumar, R., Pradeep, S., Ojesina, A. I., & Kumar, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1618275 · Cited by 53
Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet
Hsiao, P., Hsieh, T., Kuo, K., Hung, W., Tsai, K., Yang, C.-H., Yu, M., & Shin, S. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-82 · Cited by 50
Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone
Julie, N. L., Julie, I. M., Kende, A. I., & Wilson, G. L. (2008) · Diabetologia · doi:10.1007/s00125-008-1133-6 · Cited by 51
Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies
Amacher, D. E. (2010) · Toxicology · doi:10.1016/j.tox.2010.10.006 · Cited by 50
Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects
Valle, A., Catalán, V., Rodrı́guez, A., Rotellar, F., Valentí, V., Silva, C., Salvador, J., Frühbeck, G., Gómez‐Ambrosi, J., Roca, P., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02765.x · Cited by 49
Hepatic Metabolism in Liver Health and Disease
Liu, X., Wang, H., Liang, X., & Roberts, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00030-8 · Cited by 53
Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice
Choi, S., Hwang, Y., Lee, S., Jung, H.-K., Shin, T. H., Son, Y., Park, S., Han, S. J., Kim, H. J., Lee, K. W., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.034 · Cited by 47
Systematic transcriptome analysis reveals elevated expression of alcohol‐metabolizing genes in NAFLD livers
Zhu, R., Baker, S. S., Moylan, C. A., Abdelmalek, M. F., Guy, C. D., Zamboni, F., Wu, D., Lin, W., Liu, W., Baker, R. D., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4650 · Cited by 50
A theoretical study of lipid accumulation in the liver—implications for nonalcoholic fatty liver disease
Schleicher, J., Guthke, R., Dahmen, U., Dirsch, O., Holzhütter, H., & Schuster, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.016 · Cited by 48
A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes
Grattagliano, I. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i20.3007 · Cited by 48
Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation
Weng, S., Wu, J., Shen, F., Chang, Y., Su, Y., Lian, W., Tai, M., Su, C., Chuang, J., Lin, T., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05869-9 · Cited by 50
Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy
彭新桂, X.-G. P., Ju, S., 秦雨姣, Y. Q., 方芳, F. F., Cui, X., 刘国庆, G. L., 倪以成, Y. N., & Teng, G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d016691 · Cited by 47
Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
Méndez‐Sánchez, N., Córdova‐Gallardo, J., Barranco-Fragoso, B., & Eslam, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641240 · Cited by 50
Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet
Romestaing, C., Piquet, M., Letexier, D., Rey, B., Mourier, A., Servais, S., Belouze, M., Rouleau, V., Dautresme, M., Ollivier‐Hourmand, I., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00407.2007 · Cited by 47
Chronic Ethanol Consumption Lessens the Gain of Body Weight, Liver Triglycerides, and Diabetes in Obese ob/ob Mice
Fromenty, B., Vadrot, N., Massart, J., Turlin, B., Barri‐Ova, N., Lettéron, P., Fautrel, A., & Robin, M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155168 · Cited by 50
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models
Caon, E., Martins, M. C., Hodgetts, H., Blanken, L., Vilia, M. G., Levi, A., Thanapirom, K., Al‐Akkad, W., Abu‐Hanna, J., Baselli, G., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.032 · Cited by 45
A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat–high-sucrose diet-fed rats: possible implication of the sirtuin pathway
Aoun, M., Michel, F., Fouret, G., Casas, F., Jullien, M., Wrutniak‐Cabello, C., Ramos, J., Cristol, J., Coudray, C., Carbonneau, M., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510002850 · Cited by 48
Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis
Abdelmegeed, M. A., Choi, Y., Godlewski, G., Ha, S.-K., Banerjee, A., Jang, S., & Song, B. (2017) · Scientific Reports · doi:10.1038/srep39764 · Cited by 46
Melatonin improves mitochondrial respiratory chain activity and liver morphology in ob/ob mice
Solís‐Muñoz, P., Solis-Herruzo, J. A., Fernández-Moreira, D., Gómez-Izquierdo, É., García‐Consuegra, I., Muñoz‐Yagüe, T., & García‐Ruíz, I. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00868.x · Cited by 45
Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis
Gonçalves, I. O., Oliveira, P. J., Ascensão, A. A. M. R., & Magalhães, J. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12146 · Cited by 46
Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: DirectversusIndirect Mechanisms
Martel, C., Huynh, L. H., Garnier, A., Ventura‐Clapier, R., & Brenner, C. (2012) · Biochemistry Research International · doi:10.1155/2012/213403 · Cited by 47
Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis.
Surapaneni, K. M., & Jainu, M. (2014) · PubMed · Cited by 45
Ultra‐high‐field magnetic resonance spectroscopy in non‐alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non‐alcoholic steatohepatitis and advanced fibrosis
Traussnigg, S., Kienbacher, C., Gajdošík, M., Valkovič, L., Halilbasic, E., Stift, J., Rechling, C., Hofer, H., Steindl‐Munda, P., Ferenci, P., et al. (2017) · Liver International · doi:10.1111/liv.13451 · Cited by 49
Angiotensin‐(1‐7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism
Song, L., Liu, J., Shi, T., Zhang, Y., Zhong, X., Cao, X., & Yang, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001639r · Cited by 44
The role of curcumin in liver diseases
Buonomo, A. R., Scotto, R., Nappa, S., Arcopinto, M., Salzano, A., Marra, A. M., D’Assante, R., Zappulo, E., Borgia, G., & Gentile, I. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.73596 · Cited by 44
Detangling the interrelations between MAFLD, insulin resistance, and key hormones
Pal, S. C., Eslam, M., & Méndez‐Sánchez, N. (2022) · HORMONES · doi:10.1007/s42000-022-00391-w · Cited by 45
Inflammation in MASLD progression and cancer
Kim, Y. S., Park, Y., Rho, H., Yao, T., Gao, B., & Hwang, S. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101414 · Cited by 58
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
Surapaneni, K. M., Priya, V. V., & Mallika, J. (2014) · PubMed · Cited by 44
Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis
Liu, Y., Mu, D., Chen, H., Li, D., Song, J., Yuan, Ž., & Xia, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1320 · Cited by 44
Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis
Fromenty, B. (2019) · Liver Research · doi:10.1016/j.livres.2019.06.001 · Cited by 44
Changes in Key Mitochondrial Lipids Accompany Mitochondrial Dysfunction and Oxidative Stress in NAFLD
Durand, M., Coué, M., Croyal, M., Moyon, T., Tesse, A., Atger, F., Ouguerram, K., & Jacobi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9986299 · Cited by 52
Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH
Hsu, M.-J., Karkossa, I., Schäfer, I., Christ, M., Kühne, H., Schubert, K., Rolle-Kampczyk, U. E., Kalkhof, S., Nickel, S., Seibel, P., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8090350 · Cited by 43
Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease
Ma, B., Ju, A., Zhang, S., An, Q., Xu, S., Liu, J., Yu, L., Fu, Y., & Luo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01437-0 · Cited by 43
Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis
Duwaerts, C. C., & Maher, J. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0224-8 · Cited by 42
Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice
Csák, T., Dolganiuc, A., Kodys, K., Nath, B., Petrášek, J., Bala, S., Lippai, D., & Szabó, G. (2011) · Hepatology · doi:10.1002/hep.24301 · Cited by 45
Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome
Sinton, M. C., Hay, D. C., & Drake, A. J. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0702-5 · Cited by 44
A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in Rabbits
Ogawa, T., Fujii, H., Yoshizato, K., & Kawada, N. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090895 · Cited by 43

Authors: Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B.
Affiliations: Inserm (FR)
Corresponding author: Fromenty, Bernard
ORCID: Begriche, Karima
Fromenty, Bernard
Venue: Mitochondrion
Publisher: Elsevier BV
Published: 2006-02
Volume: 6
Issue: 1
Pages: 1-28
ISSN: 1567-7249 (ISSN-L)
DOI: 10.1016/j.mito.2005.10.004
OpenAlex: W1978045299
Cited by: 753
References: 348
Citations by year: 2026: 24 · 2025: 28 · 2024: 33 · 2023: 27 · 2022: 55 · 2021: 47 · 2020: 43 · 2019: 48 · 2018: 43 · 2017: 32 · 2016: 39 · 2015: 39 · 2014: 38 · 2013: 39 · 2012: 35
FWCI: 4.46
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Mitochondrion (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: mitochondrial dysfunction, nonalcoholic steatohepatitis, hepatic steatosis, respiratory chain deficiency, reactive oxygen species, lipid peroxidation, malondialdehyde, mitochondrial DNA damage, insulin resistance, drug-induced liver injury, fatty acid beta-oxidation, apoptosis, cytokines, liver fibrosis, genetic polymorphism, oxidative stress
MeSH terms: Animals, Drug Therapy, Fatty Liver, Hepatitis, Humans, Mitochondria, Liver, Mitochondrial Diseases, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks